
Indokem Ltd. (INDOKEM) Share Price Rises 10% Today as Stock Enters Top Gainers List
Updated: 7 Aug 2026 • 9:33 am
Posted by:

Indokem Ltd. rose to Rs 629.35, up 10% today. The small-cap Chemicals stock now has a market capitalisation of Rs 1,663.67 crore.
Indokem Ltd. Share Price moved to Rs 629.35 on 07 August 2026, up 10% from the previous close of Rs 572.15, taking the company’s market capitalisation to Rs 1,663.67 crore. In today’s Stock Market Today action, the move placed the small-cap Chemicals name among the visible top gainers, and that alone makes it relevant in the day’s Market News flow.
The supplied data confirms the price rise, the trading range and the turnover, but it does not establish a company-specific catalyst behind the move. Even so, the stock’s opening at Rs 583.60, low of Rs 569.95 and high of Rs 629.35 show that buyers pushed the price to the top of the intraday range early in the session. For investors searching Indokem Ltd. Share Price Today or Indokem Ltd. Stock News, that intraday structure matters because it shows strength from the opening stretch rather than a late isolated tick.
Another reason the move is being tracked is context. Indokem sits in the Chemicals industry, where the company’s valuation multiples stand far above the same-industry benchmark averages supplied in the data. At the same time, its return ratios are below industry medians, creating a mixed Fundamental Analysis picture even as the share price records a sharp single-day gain. Univest notes that this combination of strong price action and stretched headline valuation often draws attention from both short-term traders and longer-term market watchers.
What should investors monitor next? The most important verified markers are whether Indokem Ltd. Share Price holds near today’s high, whether trading participation expands beyond the reported 4,779 shares, and how the stock’s profitability and valuation compare with sector and peer benchmarks. That is the core of this Univest stock analysis.
Indokem Ltd. (INDOKEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 629.35 |
| Previous Close | Rs 572.15 |
| Today's Change | +Rs 57.2 (+10%) |
| Day Open | Rs 583.6 |
| Day High | Rs 629.35 |
| Day Low | Rs 569.95 |
| Current Volume (BSE) | 4,779 |
| BSE Traded Volume | 4,779 |
| Combined NSE + BSE Volume | 4,779 |
| Turnover | Rs 0.3 crore |
| Market Capitalisation | Rs 1,663.67 crore |
| Market Cap Category | Small Cap |
Indokem Ltd. (INDOKEM) traded at Rs 629.35. versus the previous close of Rs 572.15, a rise of 10%. The stock opened at Rs 583.6, reached Rs 629.35, touched Rs 569.95. Reported volume was 4,779.
Indokem Ltd. (INDOKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,663.67 crore |
| P/E Ratio | 712.33x |
| P/B Ratio | 33.27x |
| ROE | 9.71% |
| ROCE | 10.71% |
| EPS | Rs 0.8 |
| Dividend Yield | 0% |
Indokem Ltd. was valued at a P/E ratio of 712.33x, a P/B ratio of 33.27x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of 9.71% and ROCE of 10.71%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Per-share and shareholder-return metrics included EPS of Rs 0.8, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.
The supplied fundamentals show a sharp contrast. Indokem’s market value has climbed to Rs 1,663.67 crore, but valuation multiples are very high at 712.33 times earnings and 33.27 times book value, while return ratios of 9.71% ROE and 10.71% ROCE remain below several sector benchmarks.
Indokem Ltd. Fundamental Analysis begins with scale and valuation. The company’s market capitalisation stands at Rs 1,663.67 crore, placing it in the small-cap bracket. Its price-to-earnings ratio is 712.33, while the price-to-book ratio is 33.27. On their own, these are just valuation multiples, but against the Chemicals industry numbers supplied later in this article, they stand at the upper extreme of the dataset. That means the market is currently assigning a very rich earnings and book-value multiple to the stock relative to many listed peers in the same industry.
Profitability metrics offer a more moderate picture. Return on equity is 9.71% and return on capital employed is 10.71%. These figures show the business is generating positive returns, but they are not especially high when compared with broader same-industry medians and averages. Earnings per share are Rs 0.80, which is important because the very high P/E ratio partly reflects a low earnings base relative to the current stock price. Dividend yield is 0, indicating that the stock is not offering a current historical dividend return in the supplied data.
Indokem’s valuation profile therefore becomes the key interpretive point in today’s Indokem Ltd. Share Price rise. Investors tracking Indokem Ltd. Share Price Today may see strong price action, but the fundamental snapshot shows that the stock is priced at a substantial premium to sector norms on both earnings and book-value measures. That does not by itself confirm overvaluation or undervaluation; it simply frames investor attention correctly. Univest reads the setup as one where price momentum has outpaced the comfort offered by standard valuation ratios, making benchmark and peer comparison essential before drawing broader conclusions.
The next logical step is to place those numbers inside the Chemicals sector context and then compare Indokem directly with listed peers on valuation, return ratios and market cap.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Chemicals |
| Industry | Chemicals |
| Benchmark Scope | same industry |
| Company P/E Ratio | 712.33x |
| Benchmark Median P/E | 21.3x |
| Benchmark Average P/E | 48.29x |
| Benchmark P/E Range | 1.34x to 712.33x |
| Company P/B Ratio | 33.27x |
| Benchmark Median P/B | 1.64x |
| Company ROE | 9.71% |
| Benchmark Median ROE | 11.54% |
| Company ROCE | 10.71% |
| Benchmark Median ROCE | 13.88% |
| Company Market Capitalisation | Rs 1,663.67 crore |
| Benchmark Median Market Cap | Rs 239.71 crore |
Indokem Ltd. (INDOKEM) is classified under sector: Chemicals and industry: Chemicals.
Indokem Ltd. (INDOKEM) has a P/E ratio of 712.33x, which is above the benchmark median of 21.3x, a difference of +3,244.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Indokem Ltd. (INDOKEM) has a ROE of 9.71%, which is below the benchmark median of 11.54%, a difference of -15.86%. Indokem Ltd. (INDOKEM) has a ROCE of 10.71%, which is below the benchmark median of 13.88%, a difference of -22.84%.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
Indokem operates in the Chemicals industry, and the benchmark data is especially useful here because it covers 142 same-industry companies. The company’s valuation sits far above the industry’s central tendency, while its ROE and ROCE are below both median and average benchmark levels.
The sector snapshot defines the benchmark scope as the same industry and includes 142 companies. Within that set, Indokem’s company P/E of 712.33 is not merely above the median of 21.30 and average of 48.29; it is also equal to the maximum reported P/E in the sample. The benchmark P/E range runs from 1.34 to 712.33 across 114 companies with reported P/E data. That places Indokem at the extreme top end of the earnings-multiple range within the supplied Chemicals dataset.
The price-to-book picture is also elevated. Indokem’s P/B is 33.27, versus a median of 1.64 and average of 1.55 across 141 companies. The supplied P/B range runs from -67.90 to 42.54, so the company is again positioned toward the upper end of the sector distribution.
Profitability looks less aggressive than valuation. Indokem’s ROE of 9.71% is below the same-industry median of 11.54% and below the average of 15%. Its ROCE of 10.71% is also below the median of 13.88% and average of 17.41%. In market-cap terms, however, the company is larger than the benchmark’s typical member: Indokem’s Rs 1,663.67 crore market value is well above the sector median of Rs 239.71 crore and the average of Rs 564.78 crore, though still below the maximum of Rs 3,117.20 crore. The range itself spans from Rs 3.49 crore to Rs 3,117.20 crore.
For readers following Indokem Ltd. Stock News or looking for a Sector Analysis, the takeaway is clear. Today’s price rise comes from a company that is meaningfully larger than the median chemicals peer by market capitalisation, yet far more expensive on P/E and P/B while delivering lower-than-benchmark ROE and ROCE. That makes the stock especially interesting as a valuation outlier inside the Indian Stock Market chemicals space.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Grauer & Weil (India) Ltd. | GRAUWEIL | 3,117.2 | 19.63 | 2.8 | 14.35 | 19.47 |
| Chemplast Sanmar Ltd. | CHEMPLASTS | 3,096.58 | 0 | -30.82 | 0 | 183.45 |
| Bhansali Engineering Polymers Ltd. | BEPL | 3,023.63 | 15.23 | 2.65 | 42.11 | 56.88 |
| Rossari Biotech Ltd. | ROSSARI | 2,910.96 | 19.35 | 2.14 | 16.17 | 24.37 |
| Nocil Ltd. | NOCIL | 2,884.52 | 43.06 | 1.59 | 12.95 | 17.71 |
Indokem Ltd. (INDOKEM) has a P/E ratio of 712.33x compared with the displayed peer median of 19.35x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.71% compares with a peer median of 14.35% across the companies shown in the table. ROCE stood at 10.71% versus the displayed peer median of 24.37%, providing a capital-efficiency comparison. Indokem Ltd. (INDOKEM) has a market capitalisation of Rs 1,663.67 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Peer data shows Indokem sits below several comparable Chemicals names on return ratios while trading at a much higher earnings multiple. Its market capitalisation is mid-pack versus the listed peer set, but the valuation gap versus peers is the most striking part of the comparison.
Among the supplied peers, Grauer & Weil (India) Ltd. has a market cap of Rs 3,117.20 crore with P/E of 19.63, P/B of 2.80, ROE of 14.35% and ROCE of 19.47%. Bhansali Engineering Polymers Ltd. stands at Rs 3,023.63 crore with P/E of 15.23, P/B of 2.65, ROE of 42.11% and ROCE of 56.88%. Rossari Biotech Ltd. has a market cap of Rs 2,910.96 crore, P/E of 19.35, P/B of 2.14, ROE of 16.17% and ROCE of 24.37%. Nocil Ltd. is at Rs 2,884.52 crore with P/E of 43.06, P/B of 1.59, ROE of 12.95% and ROCE of 17.71%.
Against those numbers, Indokem’s P/E of 712.33 is dramatically higher, while its ROE of 9.71% and ROCE of 10.71% are lower than each of those four peers. Camlin Fine Sciences Ltd. offers another useful reference point: market cap Rs 2,490.53 crore, P/E 88.90, P/B 2.40, ROE 10.55% and ROCE 11.37%. Even there, Indokem trades at a much richer earnings and book-value multiple while showing slightly lower return ratios.
The broader peer set adds more context. SH Kelkar And Company Ltd. has P/E 26.55, P/B 1.68, ROE 15.21% and ROCE 9.48% at a market cap of Rs 2,308.86 crore. JG Chemicals Ltd. reports P/E 32.09, P/B 4, ROE 29.78% and ROCE 29.05% with a market cap of Rs 2,147.98 crore. Thirumalai Chemicals Ltd. has P/B 1.35, ROE 29.79% and ROCE 35.47% at Rs 2,049.40 crore. Chemplast Sanmar Ltd. stands at Rs 3,096.58 crore with P/B of -30.82, ROE of 0 and ROCE of 183.45, while JUBILANT AGRI N CON PRO L shows P/E 22.78, P/B 6.33, ROE -12.07% and ROCE 16.08% at Rs 2,869.65 crore.
Univest’s reading of this peer comparison is simple: Indokem’s current market cap is respectable within the Chemicals basket, but the stock’s valuation premium is far steeper than what its current profitability ratios alone would explain when compared with most supplied peers.
Why Investors Are Watching Indokem Ltd.
Investors are watching Indokem because today’s price rise is large enough to place the stock on the radar of traders, while the financial snapshot raises equally important questions about valuation, profitability and relative positioning inside the Chemicals industry. That combination keeps the stock in active discussion across Stock News and Market Update screens.
- Verified price action: the stock rose 10% to Rs 629.35 from Rs 572.15 and traded at the day’s high at the captured time.
- Trading participation: total reported volume was 4,779 shares on BSE, with turnover of Rs 0.30 crore.
- Fundamental context: market capitalisation is Rs 1,663.67 crore, but valuation is steep at 712.33 P/E and 33.27 P/B.
- Profitability check: ROE is 9.71% and ROCE is 10.71%, both below the same-industry medians in the supplied benchmark.
- Sector positioning: the stock sits in Chemicals, where peer P/E ratios are generally far lower than Indokem’s current multiple.
What should be monitored next is whether the stock can sustain levels closer to Rs 629.35 rather than slipping back toward the open of Rs 583.60 or the low of Rs 569.95. Investors may also keep tracking how Indokem Ltd. Share Price behaves relative to peer valuations and whether future company updates improve the gap between current market pricing and present return ratios.
About Indokem Ltd.
Indokem Ltd. operates in the Chemicals sector and the Chemicals industry. That business classification matters because it places the company inside a broad listed universe where investors often compare firms on valuation multiples, capital efficiency and market size rather than on price action alone.
Based on the supplied dataset, the company is currently valued by the market at Rs 1,663.67 crore. That makes it substantially larger than the median company in its same-industry benchmark set, where the median market capitalisation is Rs 239.71 crore and the average is Rs 564.78 crore. So while Indokem is described as a small-cap stock by market-cap category, it is not a micro-sized outlier within the listed Chemicals basket captured here.
For investors searching Indokem Ltd. Share Price, Indokem Ltd. Stock Analysis or Indokem Ltd. Company News, the useful company-level takeaway from the available data is positioning rather than promotional description. Indokem is part of an industry where peers such as Grauer & Weil, Rossari Biotech, Nocil, JG Chemicals and Thirumalai Chemicals provide market references for valuation and return ratios. That means the stock is likely to remain under scrutiny not just for day-to-day price moves but also for how its earnings profile, return metrics and market pricing compare with the wider Chemicals group. Univest therefore treats the company as a closely benchmarked listed chemicals player rather than an isolated market story.
Track Indokem Ltd. Share Price on Univest
Use Indokem Ltd. (INDOKEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Readers following Indokem Ltd. Share Price Today can use Univest to monitor live Share Price changes, day high and low, 52-week levels, market capitalisation, valuation ratios and broader stock analysis in one place. Univest also helps users track sector context, peer comparison, shareholding pattern when available, and important market insights built around verified data.
For a stock like Indokem, where today’s price rise is clear but the interpretation depends heavily on valuation and industry comparison, having price, fundamental and benchmark views together is useful. Univest keeps that perspective data-led, helping investors follow Indokem Ltd. Share Price, Market Cap and stock performance without turning a daily move into an unsupported long-term claim.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Indokem Ltd. Share Price today?
Ans. Indokem Ltd. Share Price was Rs 629.35 at the captured time on 07 August 2026. The stock was up 10% from the previous close of Rs 572.15 and was also trading at its day’s high.
Why is Indokem Ltd. rising today?
Ans. The supplied data confirms that Indokem rose 10% in today’s session, moving from a previous close of Rs 572.15 to Rs 629.35. However, the dataset establishes the price event and trading activity, not a company-specific catalyst.
What was the day range for Indokem Ltd. today?
Ans. Indokem traded between Rs 569.95 and Rs 629.35 in the session captured here. It opened at Rs 583.60, and the current traded price matched the day’s high, showing strength through early trading.
What is the market capitalisation of Indokem Ltd.?
Ans. Indokem Ltd. had a market capitalisation of Rs 1,663.67 crore in the supplied data. That places it in the small-cap category, while still making it larger than the Chemicals benchmark median market cap of Rs 239.71 crore.
How expensive is Indokem Ltd. on P/E basis?
Ans. Indokem’s P/E ratio is 712.33. In the same-industry Chemicals benchmark, the median P/E is 21.30 and the average is 48.29, which shows the stock is trading at a much richer earnings multiple than many peers.
What does Indokem’s P/B ratio indicate?
Ans. Indokem’s price-to-book ratio stands at 33.27. Against the industry median of 1.64 and average of 1.55, that places the stock at a very elevated book-value multiple within the supplied Chemicals benchmark set.
How profitable is Indokem Ltd. based on ROE and ROCE?
Ans. Indokem reported ROE of 9.71% and ROCE of 10.71% in the supplied data. Both figures are positive, but they sit below the same-industry medians of 11.54% for ROE and 13.88% for ROCE.
What are Indokem’s EPS and dividend yield?
Ans. Indokem’s earnings per share are Rs 0.80, and its dividend yield is 0 in the supplied dataset. That means the stock’s current valuation is being assessed mainly through price and earnings rather than dividend income.
How does Indokem compare with listed Chemicals peers?
Ans. Compared with peers such as Grauer & Weil, Bhansali Engineering Polymers, Rossari Biotech and Nocil, Indokem trades at a far higher P/E ratio, while its ROE and ROCE are lower than several of those companies.
What should investors monitor after today’s move?
Ans. Investors may track whether Indokem holds near Rs 629.35, how volume develops beyond 4,779 shares, and whether future financial performance supports a valuation of 712.33 times earnings and 33.27 times book value.
Recent Articles

Macrotech Developers (Lodha) Share: Pros and Cons Every Investor Must Know in 2026
7 August 2026

ITC Share: Pros and Cons Every Investor Must Know in 2026
7 August 2026

20 Microns Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
7 August 2026

USD JPY Today 7 Aug 2026: Yen Loses Half Intervention Gains
7 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Macrotech Developers (Lodha) Share: Pros and Cons Every Investor Must Know in 2026
ITC Share: Pros and Cons Every Investor Must Know in 2026
20 Microns Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast
USD JPY Today 7 Aug 2026: Yen Loses Half Intervention Gains
Tax Amendment Bill 2026: Lok Sabha Passes MDR and UPI Changes
Popular this week
Eicher Motors Share: Pros and Cons Every Investor Must Know in 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





